BROADWOOD CAPITAL INC - Q2 2018 holdings

$871 Million is the total value of BROADWOOD CAPITAL INC's 9 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .

 Value Shares↓ Weighting
STAA  STAAR SURGICAL CO$336,511,000
+109.5%
10,855,1790.0%38.64%
+65.6%
MNST  MONSTER BEVERAGE CORP NEW$273,533,000
+0.2%
4,773,7080.0%31.41%
-20.8%
IWM  ISHARES TRrussell 2000 etf$68,783,000
+7.9%
420,0000.0%7.90%
-14.7%
BTX  BIOTIME INC$61,741,000
-23.4%
29,971,5610.0%7.09%
-39.5%
AXON  AXON ENTERPRISE INC$48,021,000
+60.7%
760,0620.0%5.52%
+27.0%
MNST  MONSTER BEVERAGE CORP NEWput$45,840,000
+0.2%
800,0000.0%5.26%
-20.8%
OCX  ONCOCYTE CORPORATION$19,291,000
+21.4%
7,564,9340.0%2.22%
-4.0%
DAL  DELTA AIR LINES INC DELput$9,908,000
-9.6%
200,0000.0%1.14%
-28.6%
AST  ASTERIAS BIOTHERAPEUTICS INC$7,144,000
-6.9%
5,292,1560.0%0.82%
-26.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14
42023-11-09
42023-11-06

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (870773000.0 != 870772000.0)

Export BROADWOOD CAPITAL INC's holdings